Literature DB >> 26176042

Endoscopic Resection is Infeasible for Early Gastric Cancers with Undifferentiated Components.

Kouichi Hamabe, Jun Nishikawa, Shu Kiyotoki, Mari Saito, Takeshi Okamoto, Hideo Yanai, Minako Hirahashi, Yoshinao Oda, Keisuke Matsusaki, Toyokazu Kawano, Osamu Miura, Isao Sakaida.   

Abstract

BACKGROUND/AIMS: Aim of this study is to find subgroup of early gastric cancer with lymph node metastasis for which successive further surgical operation is needed after endoscopic resection.
METHODOLOGY: A total of 559 lesions of early gastric cancer, which had undergone curative gastrectomy, were enrolled in this study. We retrospectively investigated 10 clinicopathological factors predictive of lymph node metastasis by univariate and multivariate analysis. We showed the frequency of lymph node metastasis of subgroups in combination of independent factors selected by multivariate analysis.
RESULTS: Lymph node metastases were detected in 57 lesions (10.2%). Univariate analysis revealed that lesion size > 30 mm, undifferentiated components, sm massive invasion, lymphatic invasion and venous invasion were factors significantly correlated with lymph node metastasis. By multivariate analysis, risk factors for lymph node metastasis were lesion size > 30 mm, undifferentiated components, sm massive invasion, and lymphatic invasion, with odds ratios of 2.17, 2.30, 5.88 and 8.24, respectively. In lesions with undifferentiated components, LNM were found in all subgroups.
CONCLUSIONS: When we treat early gastric cancers contained undifferentiated components, even if they are predominantly differentiated-type intramucosal lesions, an additional surgical procedure should be considered or careful follow-up is required.

Entities:  

Mesh:

Year:  2014        PMID: 26176042

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  1 in total

1.  Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer.

Authors:  Eizaburou Hideura; Yutaka Suehiro; Jun Nishikawa; Takuya Shuto; Hiroyuki Fujimura; Shunsuke Ito; Atsushi Goto; Kouichi Hamabe; Issei Saeki; Takeshi Okamoto; Shingo Higaki; Ikuei Fujii; Chieko Suzuki; Tomomi Hoshida; Toshihiko Matsumoto; Taro Takami; Isao Sakaida; Takahiro Yamasaki
Journal:  Cancers (Basel)       Date:  2020-03-26       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.